Echo Therapeutics Inc (NASDAQ:ECTE)

2.41
Delayed Data
As of Mar 27
 -0.185 / -7.13%
Today’s Change
0.39
Today|||52-Week Range
3.47
+78.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.0019.1K19.1K19.1K
 
 
 
 
Depreciation And Amortization102.7K99.9K98.9K97.9K
 
 
 
 
 
 
Operating ExpensesGross Income-102.7K------
 
 
General Expenses3.0M2.6M3.8M2.8M
 
 
 
 
 
Research And Development1.3M1.1M1.7M1.2M
 
 
 
 
 
Total Operating Expenses3.1M2.7M3.9M2.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.1M-2.7M-3.9M-2.9M
 
 
 
 
 
Extraordinary Credit--140.0K393.0K473.0K
 
 
 
 
Extraordinary Charge-140.0K0.000.000.00
 
 
Interest Expense On Debt242.0K243.2K243.8K3.1M
 
 
 
 
 
Other Expenses0.000.001.5K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.5M-2.8M-3.8M-5.5M
 
 
 
 
 
Preferred Dividend-371.1K0.000.000.00
 
 
Net Income-3.5M-2.8M-3.8M-5.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.3M11.9M12.1M12.7M
 
 
 
 
 
Shares To Calculate EPS Diluted14.3M11.9M12.1M12.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.23-$0.31-$0.43
 
 
 
 
 
EPS Diluted-$0.27-$0.23-$0.31-$0.43
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account